Apr 15, 2020 / 05:30PM GMT
Operator
Good day, and welcome to the key opinion leader call on cardiac complications of DMD hosted by Capricor Therapeutics. I will now turn the call over to AJ Bergmann, CFO of Capricor Therapeutics. Please go ahead, Mr. Bergmann.
AJ Bergmann - Capricor Therapeutics, Inc. - CFO
Before we start, I would like to (technical difficulty) making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future research and development plans, including the anticipated conduct and timing of preclinical and clinical studies, our plans that are reported (technical difficulty) [additional our] plans regarding regulatory filings, potential regulatory developments involving product candidates and (technical difficulty) [uses] of existing cash and investment resources.
These forward-looking statements are based on current information, assumptions and expectations that are subject to change (technical difficulty) involve a
Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP-1002 Transcript
Apr 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers